Carna Biosciences (TSE:4572) Days Sales Outstanding : 220.29 (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Days Sales Outstanding?

Carna Biosciences's average Accounts Receivable for the three months ended in Mar. 2024 was 円437 Mil. Carna Biosciences's Revenue for the three months ended in Mar. 2024 was 円181 Mil. Hence, Carna Biosciences's Days Sales Outstanding for the three months ended in Mar. 2024 was 220.29.

The historical rank and industry rank for Carna Biosciences's Days Sales Outstanding or its related term are showing as below:

TSE:4572' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.69 Med: 61.97 Max: 187.7
Current: 62.98

During the past 13 years, Carna Biosciences's highest Days Sales Outstanding was 187.70. The lowest was 11.69. And the median was 61.97.

TSE:4572's Days Sales Outstanding is ranked better than
57.87% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs TSE:4572: 62.98

Carna Biosciences's Days Sales Outstanding increased from Mar. 2023 (69.87) to Mar. 2024 (220.29).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Carna Biosciences Days Sales Outstanding Historical Data

The historical data trend for Carna Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Days Sales Outstanding Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

11.69

39.72

124.20

187.70

108.95

Carna Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															69.87	60.01	70.28	45.80	220.29

Competitive Comparison of Carna Biosciences's Days Sales Outstanding

For the Biotechnology subindustry, Carna Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carna Biosciences's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Days Sales Outstanding falls into.

Carna Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Carna Biosciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (182.426	+	788.195)	/	2 )	/	1625.889	*	365
=	485.3105					/	1625.889	*	365
=	108.95

Carna Biosciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (788.195	+	85.102)	/	2 )	/	180.87	*	365 / 4
=	436.6485					/	180.87	*	365 / 4
=	220.29

Carna Biosciences (TSE:4572) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Carna Biosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences (TSE:4572) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines